Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	354
Overall Study	STARTED	Naproxen	1,063
Overall Study	STARTED	Fasinumab 1 mg SC Q8W	551
Overall Study	STARTED	Fasinumab 1 mg SC Q4W	1,054
Overall Study	STARTED	Fasinumab 3mg Q4W	145
Overall Study	STARTED	Fasinumab 6mg Q8W	140
Overall Study	As Treated	Placebo	352
Overall Study	As Treated	Naproxen	1,056
Overall Study	As Treated	Fasinumab 1 mg SC Q8W	554
Overall Study	As Treated	Fasinumab 1 mg SC Q4W	1,052
Overall Study	As Treated	Fasinumab 3mg Q4W	145
Overall Study	As Treated	Fasinumab 6mg Q8W	139
Overall Study	COMPLETED	Placebo	299
Overall Study	COMPLETED	Naproxen	919
Overall Study	COMPLETED	Fasinumab 1 mg SC Q8W	465
Overall Study	COMPLETED	Fasinumab 1 mg SC Q4W	867
Overall Study	COMPLETED	Fasinumab 3mg Q4W	102
Overall Study	COMPLETED	Fasinumab 6mg Q8W	99
Overall Study	NOT COMPLETED	Placebo	55
Overall Study	NOT COMPLETED	Naproxen	144

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03161093/flow